[1]
“Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma”, Radiol Oncol, vol. 41, no. 1, Mar. 2007, Accessed: Nov. 04, 2026. Available: https://radioloncol.com/index.php/ro/article/view/1240